tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VTGN Stock Latest News

VISTAGEN THERAPEUTICS CLASS ACTION: LEVI & KORSINSKY, LLP EXPLAINS LEAD PLAINTIFF DEADLINE AND PROCESS
Class ActionVISTAGEN THERAPEUTICS CLASS ACTION: LEVI & KORSINSKY, LLP EXPLAINS LEAD PLAINTIFF DEADLINE AND PROCESS
7d ago
VTGN
Vistagen Facing Class Action over Social Anxiety Disorder Drug Claims
PremiumMarket News
Vistagen Facing Class Action over Social Anxiety Disorder Drug Claims
10d ago
VTGN
LEVI & KORSINSKY, LLP: UNDERSTANDING THE LEGAL FRAMEWORK FOR THE VISTAGEN THERAPEUTICS SECURITIES CLASS ACTION
PremiumClass Action
LEVI & KORSINSKY, LLP: UNDERSTANDING THE LEGAL FRAMEWORK FOR THE VISTAGEN THERAPEUTICS SECURITIES CLASS ACTION
10d ago
VTGN
High-Risk Warning: Analyst Flags Significant Uncertainties for Vistagen Therapeutics Investors
PremiumCompany Announcements
High-Risk Warning: Analyst Flags Significant Uncertainties for Vistagen Therapeutics Investors
21d ago
VTGN
Vistagen Therapeutics Balances Progress and Uncertainty
PremiumCompany Announcements
Vistagen Therapeutics Balances Progress and Uncertainty
22d ago
VTGN
Vistagen reports Q3 EPS (45c), consensus (49c)
PremiumThe FlyVistagen reports Q3 EPS (45c), consensus (49c)
23d ago
VTGN
VTGN Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
VTGN Earnings this Week: How Will it Perform?
25d ago
VTGN
VistaGen Receives Nasdaq Notice on Minimum Bid Compliance
Premium
Company Announcements
VistaGen Receives Nasdaq Notice on Minimum Bid Compliance
29d ago
8K
VTGN
Vistagen Therapeutics (VTGN) Faces Securities Litigation Following 80% Stock Collapse [January 2026]
PremiumClass Action
Vistagen Therapeutics (VTGN) Faces Securities Litigation Following 80% Stock Collapse [January 2026]
1M ago
VTGN
Vistagen Drug Trial Collapse Triggers Investor Lawsuit Wave
PremiumClass Action
Vistagen Drug Trial Collapse Triggers Investor Lawsuit Wave
2M ago
VTGN
VistaGen updates corporate presentation highlighting neuroscience pipeline
PremiumCompany Announcements
VistaGen updates corporate presentation highlighting neuroscience pipeline
2M ago
8K
VTGN
VistaGen’s PALISADE-3 Trial Fails Primary Endpoint in SAD
PremiumCompany Announcements
VistaGen’s PALISADE-3 Trial Fails Primary Endpoint in SAD
2M ago
8K
VTGN
Vistagen downgraded to Hold from Buy at Jefferies
PremiumThe FlyVistagen downgraded to Hold from Buy at Jefferies
3M ago
VTGN
Vistagen downgraded to Hold at Jefferies after social anxiety study miss
Premium
The Fly
Vistagen downgraded to Hold at Jefferies after social anxiety study miss
3M ago
VTGN
Vistagen downgraded to Hold from Buy at Maxim
Premium
The Fly
Vistagen downgraded to Hold from Buy at Maxim
3M ago
VTGN
Vistagen downgraded to Market Perform from Outperform at William Blair
PremiumThe Fly
Vistagen downgraded to Market Perform from Outperform at William Blair
3M ago
VTGN
Vistagen downgraded to Market Perform at William Blair after PALISADE-3 miss
PremiumThe Fly
Vistagen downgraded to Market Perform at William Blair after PALISADE-3 miss
3M ago
VTGN
Vistagen downgraded to Hold at Stifel after PALISADE-3 study disappoints
PremiumThe Fly
Vistagen downgraded to Hold at Stifel after PALISADE-3 study disappoints
3M ago
VTGN
Vistagen downgraded to Hold from Buy at Stifel
PremiumThe Fly
Vistagen downgraded to Hold from Buy at Stifel
3M ago
VTGN
Vistagen downgraded to Neutral from Buy at Lucid Capital
PremiumThe FlyVistagen downgraded to Neutral from Buy at Lucid Capital
3M ago
VTGN
Vistagen SAD study did not achieve primary endpoint
Premium
The Fly
Vistagen SAD study did not achieve primary endpoint
3M ago
VTGN
VistaGen Therapeutics trading resumes
Premium
The Fly
VistaGen Therapeutics trading resumes
3M ago
VTGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >